Low-Dose THC Changed How Mice Responded to MDMA Rewards in Both Directions
In mice, low-dose THC made sub-threshold MDMA rewarding but reduced the reward from higher MDMA doses, with both drugs converging on dopamine signaling in the brain's reward center.
Quick Facts
What This Study Found
Researchers tested how THC and MDMA interact when given together to mice, using reward-based behavioral tests and brain dopamine measurements.
At low doses, THC and MDMA produced a synergistic reward effect: combining sub-effective doses of both drugs (THC 0.3 mg/kg + MDMA 3 mg/kg) produced place preference, while neither alone did at those doses. THC pretreatment also enabled mice to self-administer a sub-threshold MDMA dose.
At higher MDMA doses, the pattern reversed: THC combined with a fully effective MDMA dose (10 mg/kg) actually decreased place preference, suggesting a biphasic interaction.
In the brain's reward center (nucleus accumbens), THC alone increased dopamine release, while low-dose MDMA alone did not. When MDMA was given before THC, dopamine levels dropped relative to THC alone. The order of administration mattered for the neurochemical effects.
Key Numbers
THC 0.3 mg/kg + MDMA 3 mg/kg produced CPP; neither alone did at these doses. MDMA 10 mg/kg + THC 0.3 mg/kg decreased CPP vs. MDMA 10 mg/kg alone. THC alone increased dopamine in nucleus accumbens. MDMA before THC reduced dopamine relative to THC alone.
How They Did This
Mice underwent conditioned place preference (CPP) testing and operant self-administration with various THC/MDMA combinations. In vivo microdialysis measured dopamine outflow in the nucleus accumbens. The study examined dose-dependent and order-dependent interactions.
Why This Research Matters
Cannabis and MDMA are frequently co-used recreationally. This study showed their interaction on reward pathways is not simply additive but complex and dose-dependent, with low doses enhancing each other's rewarding effects and higher doses producing different patterns.
The Bigger Picture
This study revealed that cannabis-MDMA interactions on reward circuitry are bidirectional and dose-dependent, which has implications for understanding polysubstance use patterns and addiction risk in people who use both drugs.
What This Study Doesn't Tell Us
Mouse reward behavior may not directly translate to human subjective experience. The doses used were chosen for experimental precision and may not reflect typical recreational use patterns. Only acute interactions were studied.
Questions This Raises
- ?Does the order of cannabis and MDMA use matter for the subjective experience in humans?
- ?Could the dose-dependent reversal of reward effects explain some patterns of co-use behavior?
Trust & Context
- Key Stat:
- Low-dose THC + MDMA produced reward effects that neither drug achieved alone
- Evidence Grade:
- This is an animal study using multiple behavioral and neurochemical measures, providing preliminary mechanistic insights that may not directly translate to human experience.
- Study Age:
- Published in 2007. Research on cannabis-MDMA interactions has continued but remains limited, particularly in human studies.
- Original Title:
- Behavioural and neurochemical effects of combined MDMA and THC administration in mice.
- Published In:
- Psychopharmacology, 195(2), 255-64 (2007)
- Authors:
- Robledo, Patricia(3), Trigo, Jose M(6), Panayi, Fany, de la Torre, Rafael, Maldonado, Rafael
- Database ID:
- RTHC-00289
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Does cannabis make MDMA more addictive?
This mouse study found that low-dose THC made low-dose MDMA rewarding when it otherwise wouldn't be, which could theoretically increase addiction risk. However, at higher doses the interaction reversed, making the relationship complex.
What is conditioned place preference?
A behavioral test where animals associate one location with a drug experience. If they later prefer that location, it indicates the drug was rewarding. It's widely used to study drug reward and addiction potential in animal research.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
- thc-and-antibiotics-safe-cannabis-while-on
- thc-and-caffeine-most-common-drug-combo
- thc-and-diabetes-medication-blood-sugar
Cite This Study
https://rethinkthc.com/research/RTHC-00289APA
Robledo, Patricia; Trigo, Jose M; Panayi, Fany; de la Torre, Rafael; Maldonado, Rafael. (2007). Behavioural and neurochemical effects of combined MDMA and THC administration in mice.. Psychopharmacology, 195(2), 255-64.
MLA
Robledo, Patricia, et al. "Behavioural and neurochemical effects of combined MDMA and THC administration in mice.." Psychopharmacology, 2007.
RethinkTHC
RethinkTHC Research Database. "Behavioural and neurochemical effects of combined MDMA and T..." RTHC-00289. Retrieved from https://rethinkthc.com/research/robledo-2007-behavioural-and-neurochemical-effects
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.